Company Search:
Advanced Search
Sponsored Links
Lixte Biotechnology Holdings, Incorporation Company Snapshot
Lixte Biotechnology Holdings, Incorporation operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Lixte Biotechnology Holdings, Incorporation with three other companies in this sector in UNITED STATES : Can Fite Biopharma Ltd (2015 sales of $165,463.19 ), Regen Biopharma Inc ($192,000.00 ), and TG Therapeutics Inc ($152,381.00 of which 100% was License Revenue).

Sales Analysis.
  Stock Performance Chart for Lixte Biotechnology Holdings, Incorporation
  Stock Data: Recent Stock Performance:
  Current Price (5/20/2020): .90
(Figures in U.S. Dollars)
1 Week 0.0%   13 Weeks 0.0%  
4 Weeks -9.1%   52 Weeks -23.1%  
Lixte Biotechnology Holdings, Incorporation Key Data:
  Ticker: LIXT Country: United States
  Exchanges: OTC Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2015 Sales 200,000
(Year Ending Jan 2016).
  Currency: U.S. Dollars Market Cap: 60,341,233
  Fiscal Yr Ends: December Shares Outstanding: 67,045,814
  Share Type: Common Closely Held Shares: 57,916,607
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.